BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 23078734)

  • 21. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions.
    Assali A; Vaduganathan M; Vaknin-Assa H; Lev EI; Brosh D; Teplitsky I; Bental T; Battler A; Kornowski R
    Am J Cardiol; 2012 Jun; 109(11):1563-8. PubMed ID: 22440117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
    Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial.
    Palmerini T; Dangas G; Mehran R; Caixeta A; Généreux P; Fahy MP; Xu K; Cristea E; Lansky AJ; Stone GW
    Circ Cardiovasc Interv; 2011 Dec; 4(6):577-84. PubMed ID: 22028471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial.
    Brugaletta S; Sabate M; Martin-Yuste V; Masotti M; Shiratori Y; Alvarez-Contreras L; Cequier A; Iñiguez A; Serra A; Hernandez-Antolin R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Gomez-Lara J; Backx B; Serruys PW
    Int J Cardiol; 2013 Oct; 168(3):2632-6. PubMed ID: 23578890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
    Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical outcome in STEMI patients treated with primary PCI and drug-eluting or bare-metal stents: insights from a high-volume single-center registry.
    Pedersen S; Galatius S; Mogelvang R; Abildstrom SZ; Sorensen R; Galloe A; Abildgaard U; Hansen P; Davidsen U; Iversen A; Bech J; Madsen JK; Jensen JS
    J Invasive Cardiol; 2011 Aug; 23(8):328-33. PubMed ID: 21828395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
    N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time course, predictors and clinical implications of stent thrombosis following primary angioplasty. Insights from the DESERT cooperation.
    De Luca G; Dirksen MT; Spaulding C; Kelbæk H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Diaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Suryapranata H; Stone GW;
    Thromb Haemost; 2013 Oct; 110(4):826-33. PubMed ID: 23864101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Maeng M; Thayssen P; Kaltoft A; Tilsted HH; Bøttcher M; Lassen JF; Hansen KN; Krusell LR; Rasmussen K; Pedersen KE; Pedersen L; Paaske Johnsen S; Sørensen HT; Thuesen L
    Circ Cardiovasc Interv; 2008 Dec; 1(3):176-84. PubMed ID: 20031676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do patients with drug-eluting stent thrombosis have a similar prognosis to patients presenting with st-Elevation myocardial infarction of de novo lesions?
    Belle L; Mahmoudi M; Delhaye C; Ben-Dor I; Maluenda G; Gaglia MA; Torguson R; Satler LF; Pichard AD; Waksman R
    J Interv Cardiol; 2011 Aug; 24(4):320-5. PubMed ID: 21535151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
    Stone SG; Serrao GW; Mehran R; Tomey MI; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Brener SJ; Dangas G; Stone GW
    Circ Cardiovasc Interv; 2014 Aug; 7(4):543-51. PubMed ID: 24939928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trials.
    Hao PP; Chen YG; Wang XL; Zhang Y
    Tex Heart Inst J; 2010; 37(5):516-24. PubMed ID: 20978561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
    De Luca G; Dirksen MT; Spaulding C; Kelbaek H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Díaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Cortese G; Suryapranata H; Stone GW;
    Arch Intern Med; 2012 Apr; 172(8):611-21; discussion 621-2. PubMed ID: 22529227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.
    Schoos MM; Kelbæk H; Kofoed KF; Køber L; Kløvgaard L; Helqvist S; Engstrøm T; Saunamäki K; Jørgensen E; Holmvang L; Clemmensen P
    Am J Cardiol; 2011 Jun; 107(11):1597-603. PubMed ID: 21439539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of late and very late thrombosis of drug eluting stents.
    Mishkel GJ; Moore AL; Markwell S; Shelton ME
    Am Heart J; 2008 Jul; 156(1):141-7. PubMed ID: 18585509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina--comparison of the effects of drug-eluting versus bare-metal stents.
    Leibundgut G; Nietlispach F; Pittl U; Brunner-La Rocca H; Kaiser CA; Pfisterer ME
    Am Heart J; 2009 Aug; 158(2):271-6. PubMed ID: 19619705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome.
    Beinart R; Abu Sham'a R; Segev A; Hod H; Guetta V; Shechter M; Boyko V; Behar S; Matetzky S
    Am Heart J; 2010 Jan; 159(1):118-24. PubMed ID: 20102877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry.
    Costa JR; Sousa A; Moreira AC; Costa RA; Cano M; Maldonado G; Campos C; Carballo M; Pavanello R; Sousa JE
    JACC Cardiovasc Interv; 2010 Jan; 3(1):12-8. PubMed ID: 20129562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.